Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Intrauterine lavage therapy
The First People's Hospital of Lianyungang
Intrauterine Adhesions
1 trial -
Intravenous Anesthetic Induction with Ciprofol for Painless Colonoscopy in Elderly Patients
The First People's Hospital of Lianyungang
Ciprofol
1 trial -
Intravenous Vitamin C
United Therapeutics Europe Ltd
Burns
1 trial -
Intravenous administration of ferric carboxymaltose
United Therapeutics Europe Ltd
Lung Hypoxia
1 trial -
Intravenous sedation
United Therapeutics Europe Ltd
Lower Back Pain
1 trial -
Intravenous thrombolysis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Intravenous tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Catheter Site Discomfort
1 trial -
Ipilimumab
Iovance Biotherapeutics B.V.
Metastatic Melanoma
1 trial -
Irinotecan Hydrochloride Liposome Injection；Carboplatin Injection；Serplulimab Injection
The First People's Hospital of Lianyungang
Small Cell Lung Cancer
1 trial -
Iron sucrose, Human Erythropoietin Injection, Vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
Ivarmacitinib tablet
The First People's Hospital of Lianyungang
Polymyalgia Rheumatics (PMR)
1 trial -
JAK Inhibitor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Antisynthetase Syndrome
1 trial -
Jelly confectionary Snakes
United Therapeutics Europe Ltd
POSTOP NAUSEA VOMITING
1 trial -
Jianpixiaozhong particles and Wuse Dietotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Idiopathic Membranous Nephropathy
1 trial -
Kava (Piper methysticum) extract
The First People's Hospital of Lianyungang
Sleep
1 trial -
Ketamine
The First People's Hospital of Lianyungang
Intensive Care Unit
1 trial -
Ketogenic Diet
United Therapeutics Europe Ltd
CNS Oxygen Toxicity, Ketogenic Diet
1 trial -
Ketogenic diet
United Therapeutics Europe Ltd
Heart Failure With Preserved Ejection Fraction
1 trial -
Ketogenic food products
United Therapeutics Europe Ltd
Oxygen Toxicity
2 trials -
Ketone ester
United Therapeutics Europe Ltd
Ketosis
1 trial -
Ketone ester
COGNITION THERAPEUTICS INC
Hypoxia
2 trials -
Kunxian capsule
The First People's Hospital of Lianyungang
Diabetic Nephropathy
1 trial -
Kuvan
BioMarin Pharmaceutical Australia Pty Ltd
Heart Failure
1 trial -
L-Carnitine tartrate
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources